Primary information |
---|
PRRID | PRRID_1380 |
Ligand Name | IMO-2055 |
Source | NA |
Sequence of ligand | NA |
Length | NA |
Type | Nucleic Acid |
Occurence | Synthetic |
Role of Ligand | it enhances the efficacy of antitumor agents through immune stimulation |
Name of receptor | Toll-like receptor 9 (TLR9) |
Type of receptor | Toll-like receptor (TLR) |
Source | Human patients with advanced non-small cell lung cancer (nSClC) |
Localization | monocyte/macrophages, plasmacytoid DCs and B-lymphocytes |
Domain | cell compartment |
Sequence of Receptor | Q9NR96.fasta |
Swiss prot ID | Q9NR96 |
Length Of Receptor | 1032 |
Function | TLR9 plays a crucial role in breaking tolerance and developing autoimmunity |
Assay used | NA |
PMID | 24770667 |
Year of Publication | 2014 |
Pubchem assay | Pubchem_assay |
Primary information |
---|
PRRID | PRRID_1380 |
Ligand Name | IMO-2055 |
Source | NA |
Sequence of ligand | NA |
Length | NA |
Type | Nucleic Acid |
Occurence | Synthetic |
Role of Ligand | it enhances the efficacy of antitumor agents through immune stimulation |
Name of receptor | Toll-like receptor 9 (TLR9) |
Type of receptor | Toll-like receptor (TLR) |
Source | Human patients with advanced non-small cell lung cancer (nSClC) |
Localization | monocyte/macrophages, plasmacytoid DCs and B-lymphocytes |
Domain | cell compartment |
Sequence of Receptor | Q9NR96.fasta |
Swiss prot ID | Q9NR96 |
Length Of Receptor | 1032 |
Function | TLR9 plays a crucial role in breaking tolerance and developing autoimmunity |
Assay used | NA |
PMID | 24770667 |
Year of Publication | 2014 |
Pubchem assay | Pubchem_assay |